Is telehealth allowed to prescribe Ozempic in Illinois?

If you’ve been curious about medications like Wegovy, Ozempic, or Mounjaro for weight management but aren’t sure whether you can access them through telehealth, you’re not alone. With the rise of online healthcare and GLP-1 medications becoming household names, many people wonder: Can I legally get these prescriptions without visiting a doctor’s office?

The short answer is yes—in most cases, you can obtain weight loss medications through legitimate telehealth services. But the details matter, especially since regulations vary by state and your eligibility depends on meeting specific medical criteria.

In this comprehensive guide, we’ll walk you through everything you need to know about getting weight loss medication via telehealth in 2025, including federal rules, state-specific requirements, provider qualifications, and what to expect during the process.

Understanding Federal Telehealth Rules for Weight Loss Medications

The Good News: GLP-1 Medications Are Not Controlled Substances

One of the most important things to understand is that popular weight loss medications like Wegovy (semaglutide 2.4mg), Ozempic (semaglutide, approved for diabetes but used off-label for weight loss), and Mounjaro/Zepbound (tirzepatide) are not controlled substances under federal law.

This distinction is crucial because the Ryan Haight Act—a federal law requiring an in-person exam before prescribing controlled substances via telehealth—does not apply to these medications. Unlike medications such as Adderall or other stimulants that fall under DEA scheduling, GLP-1 medications can be prescribed through telehealth consultations without federal restrictions requiring an initial face-to-face visit.

COVID-Era Flexibilities and Current Status

During the COVID-19 pandemic, federal regulators temporarily relaxed many telehealth restrictions, including those for controlled medications. As of December 2025, the DEA has extended these telehealth flexibilities for controlled substances through December 31, 2025, with expectations for further extensions into 2026.

However, since weight loss medications like semaglutide and tirzepatide aren’t controlled substances, they’ve always been eligible for telehealth prescribing under federal law—pandemic or not. The continued telehealth expansion has simply made these services more accessible and normalized across the healthcare system.

Bottom line: From a federal regulatory standpoint, there are no special barriers preventing licensed healthcare providers from prescribing GLP-1 weight loss medications via telehealth, as long as they establish an appropriate patient-provider relationship.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-Specific Telehealth Requirements: What You Need to Know

While federal law allows telehealth prescribing of weight loss medications, state regulations add an extra layer of requirements that can vary significantly depending on where you live. Some states have minimal restrictions, while others require initial in-person visits or mandate specific follow-up protocols.

States Requiring an Initial In-Person Exam

Several states require patients to have at least one in-person physical examination before or shortly after starting weight loss medication through telehealth:

Arkansas maintains some of the nation’s strictest telemedicine regulations, requiring an initial in-person encounter to establish the patient-provider relationship before prescribing weight loss medications.

Georgia requires an in-person physical exam prior to prescribing obesity medications via telehealth, though recent legislative changes (effective July 2024) have expanded prescribing authority for nurse practitioners and physician assistants.

Delaware, Mississippi, North Dakota, South Carolina, and Texas all have policies or medical board guidance indicating that an initial in-person evaluation is expected before telehealth management of weight loss medications can begin.

New Jersey takes this requirement further, mandating a comprehensive initial evaluation that includes physical examination, laboratory work, psychological screening, and documentation of a personalized diet and exercise plan.

States with Additional Follow-Up Requirements

Beyond initial visits, some states impose ongoing monitoring requirements:

Florida law requires patients receiving weight loss medications to have a BMI of 30 or higher (or 27+ with comorbidities) and mandates follow-up appointments at least once every three months during treatment.

Virginia requires not only an initial in-person exam with lab work and a customized lifestyle plan but also a follow-up visit within 30 days of starting any weight loss medication. Regular monitoring continues throughout treatment.

Connecticut requires that obesity treatment include behavioral counseling and documentation of diet and exercise recommendations alongside any medication therapy.

States with Minimal Restrictions

Many states have embraced telehealth with fewer barriers:

California, Illinois, New York, Pennsylvania, and Washington allow weight loss medications to be prescribed entirely through telehealth without mandating in-person visits, as long as providers meet appropriate standards of care.

These states recognize that a thorough video consultation, combined with patient-reported measurements and medical history, can establish a legitimate patient-provider relationship sufficient for prescribing non-controlled medications.

Who Can Prescribe Weight Loss Medications via Telehealth?

Understanding provider qualifications is essential, as you may encounter different types of healthcare professionals when seeking telehealth weight loss treatment.

Physicians (MDs and DOs)

All states allow licensed physicians—both medical doctors (MDs) and doctors of osteopathy (DOs)—to prescribe GLP-1 weight loss medications via telehealth, provided they’re licensed in the state where the patient is physically located during the consultation.

Nurse Practitioners (NPs)

The prescribing authority for nurse practitioners varies considerably by state:

Full Practice Authority States: As of 2025, 26 states plus DC allow nurse practitioners to practice independently without physician oversight after meeting experience requirements. These include Arizona, Colorado, Connecticut, Hawaii, Idaho, Maine, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota, Vermont, and Washington, among others.

Reduced Practice Authority States: Many states allow NPs to prescribe medications including GLP-1s but require a collaborative agreement or supervisory relationship with a physician. Examples include Arkansas, Delaware, Florida, Georgia, Illinois, Mississippi, New Jersey, Pennsylvania, South Carolina, Texas, and Virginia.

Important Note: Even in states requiring physician collaboration, NPs can legally prescribe weight loss medications—they just need appropriate oversight arrangements in place.

Physician Assistants (PAs)

Physician assistants can prescribe weight loss medications in all states, though they typically work under physician supervision or collaboration agreements. The specific requirements vary by state, but PAs are widely utilized in telehealth weight management programs.

Medical Eligibility: Who Qualifies for Weight Loss Medications?

Reputable telehealth providers don’t simply hand out prescriptions to anyone who asks. These are powerful medications intended for people with legitimate medical needs.

Standard Eligibility Criteria

Most healthcare providers follow FDA-approved indications and clinical guidelines:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related comorbidity such as:
• Type 2 diabetes
• High blood pressure
• High cholesterol
• Sleep apnea
• Cardiovascular disease

Providers will verify your height and weight (often requiring photos of you on a scale or video verification) and calculate your BMI during the intake process.

Contraindications and Red Flags

You will not qualify for GLP-1 weight loss medications if you have:

• Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)—all GLP-1 medications carry an FDA boxed warning about thyroid C-cell tumors
• Current pregnancy or plans to become pregnant (must discontinue at least 2 months before conception)
• History of severe pancreatitis
• Active gallbladder disease
• Severe gastrointestinal disorders (such as gastroparesis or inflammatory bowel disease)
• History of eating disorders (may require additional evaluation)

Legitimate telehealth providers screen carefully for these conditions through detailed medical history questionnaires and virtual consultations.

Lifestyle Modification Requirements

Weight loss medications work best—and are medically appropriate—only when combined with lifestyle changes. Expect providers to:

• Ask about your diet and exercise history
• Discuss realistic weight loss goals (typically 5-15% of body weight over several months)
• Require commitment to nutritional changes and increased physical activity
• Provide or recommend behavioral counseling resources

If you’re only slightly overweight or looking for a quick cosmetic fix without lifestyle commitment, reputable providers will likely recommend non-medication approaches first.

The Telehealth Weight Loss Medication Process: What to Expect

Understanding the typical patient journey can help you navigate telehealth services with confidence.

Step 1: Initial Consultation and Medical Screening

Your first interaction will involve:

• Comprehensive medical history: Including current medications, allergies, past medical conditions, surgical history, and family medical history
• Weight and health metrics: Current weight, height, blood pressure (if available), recent lab work (some providers may require labs like A1C, thyroid function, or metabolic panel)
• Video consultation: A live video appointment with a licensed provider (physician, NP, or PA) to review your information, discuss your weight loss goals, and determine if medication is appropriate
• Informed consent: Discussion of potential side effects (nausea, vomiting, diarrhea, constipation, gallstones, etc.), alternative treatments, and commitment to follow-up

This initial evaluation typically takes 20-45 minutes and should feel thorough—not rushed.

Step 2: Prescription and Pharmacy Coordination

If you qualify, your provider will:

• Send an electronic prescription to your chosen pharmacy (most states require e-prescribing for all medications)
• Verify insurance coverage or discuss cash-pay pricing (GLP-1 medications can be expensive—$900-$1,300/month without insurance)
• Provide injection training resources (these are self-administered subcutaneous injections)
• Schedule your first follow-up appointment

Important: Legitimate providers will only prescribe FDA-approved, brand-name medications from licensed U.S. pharmacies. Be extremely cautious of services offering ‘compounded’ versions—the FDA banned most compounding of semaglutide for weight loss in May 2025 due to safety concerns.

Step 3: Ongoing Monitoring and Follow-Up

Weight loss medication isn’t a ‘set it and forget it’ treatment:

• Initial follow-up: Usually within 2-4 weeks to assess tolerance and side effects
• Regular check-ins: Monthly or every 2-3 months to monitor weight loss progress, adjust dosing (many patients start on lower doses and titrate up), and screen for complications
• Lab monitoring: Periodic blood work to check metabolic parameters, thyroid function, and ensure safety
• Dose adjustments: Most patients start on lower doses (e.g., Wegovy 0.25mg weekly) and gradually increase to therapeutic doses (2.4mg weekly) over 16-20 weeks

Some states legally mandate specific follow-up schedules (Florida requires visits every 3 months; Virginia mandates a 30-day follow-up), but even in states without formal requirements, responsible telehealth providers maintain regular monitoring.

Step 4: Long-Term Management

Weight loss medication is typically a long-term commitment:

• Duration of treatment: Many patients stay on medication for a year or longer; some may need indefinite treatment to maintain weight loss
• Lifestyle integration: Ongoing support for diet, exercise, and behavioral changes
• Plateau management: Adjusting approach when weight loss stalls
• Discontinuation planning: If and when you stop medication, providers should help you transition to maintain your results

How Klarity Health Makes Telehealth Weight Loss Safe and Accessible

At Klarity Health, we’ve designed our telehealth weight management program with both accessibility and safety as top priorities.

Licensed Providers in Your State

We work exclusively with board-certified physicians and experienced nurse practitioners who are fully licensed in your state. This ensures compliance with all state-specific telehealth and prescribing regulations, whether you’re in a state with minimal restrictions or one requiring more comprehensive oversight.

Thorough Medical Evaluation

Our intake process includes:

• Detailed health questionnaires covering medical history, current medications, and contraindications
• Live video consultations (not just text-based questionnaires) with licensed providers
• Review of recent lab work or coordination of necessary testing
• Transparent discussion of risks, benefits, and alternatives

We don’t guarantee prescriptions—our providers make individualized medical decisions based on your unique situation.

Transparent Pricing and Insurance

One of the biggest challenges with weight loss medications is cost. Klarity Health offers:

• Insurance acceptance: We work with major insurance plans and handle prior authorization when needed
• Cash-pay options: Transparent pricing for patients who prefer to pay out-of-pocket or whose insurance doesn’t cover weight loss medications
• No hidden fees: Clear breakdown of consultation costs, medication costs, and any follow-up fees upfront

Ongoing Support and Monitoring

Weight loss is a journey, not a destination. Our program includes:

• Regular follow-up appointments to monitor progress and side effects
• Coordination with your primary care provider (with your permission)
• Access to nutritional guidance and lifestyle coaching resources
• Adjustments to your treatment plan as needed

Convenience Without Compromising Care

We understand that busy schedules and limited access to specialists are often barriers to weight management. Klarity Health offers:

• Flexible appointment scheduling: Evening and weekend availability
• Fast appointment access: Often within days, not weeks or months
• Prescription delivery: Medications shipped directly to your home or local pharmacy
• Virtual check-ins: No need to take time off work or arrange transportation for routine follow-ups

Red Flags: How to Spot Questionable Telehealth Weight Loss Services

Unfortunately, the popularity of medications like Wegovy and Ozempic has attracted some less-than-reputable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Proper Evaluation

Red flag: Services that promise you’ll get a prescription or offer ‘no doctor visit required’ approaches.

Why it’s concerning: Federal and state laws require establishment of a legitimate patient-provider relationship, which means an appropriate medical evaluation. Any service guaranteeing a prescription before assessing your medical history is operating outside legal and ethical boundaries.

Compounded or Non-FDA-Approved Medications

Red flag: Offers for ‘compounded semaglutide,’ medications from overseas pharmacies, or suspiciously cheap alternatives to brand-name drugs.

Why it’s concerning: The FDA banned routine compounding of semaglutide in May 2025 after determining the shortage had resolved. Compounded versions may have inconsistent dosing, contamination risks, or lack proper sterility. Overseas medications aren’t FDA-regulated and may be counterfeit.

Lack of Follow-Up or Monitoring

Red flag: Services that prescribe medication but don’t schedule follow-up appointments or monitor for side effects.

Why it’s concerning: GLP-1 medications require ongoing monitoring for efficacy and safety. Responsible providers check in regularly, adjust doses, and watch for complications like gallstones or pancreatitis.

No Provider Credentials or License Verification

Red flag: Unclear information about who your provider is, where they’re licensed, or their qualifications.

Why it’s concerning: Telehealth providers must be licensed in the state where you’re located. Services that won’t clearly identify their providers or verify credentials may be operating illegally.

Pressure Tactics or Unrealistic Claims

Red flag: Marketing that promises rapid weight loss, downplays side effects, or uses high-pressure sales tactics.

Why it’s concerning: Weight loss with GLP-1 medications is gradual (typically 1-2 pounds per week) and requires lifestyle changes. Services making unrealistic promises or minimizing risks aren’t prioritizing your safety.

The Future of Telehealth for Weight Loss Treatment

The telehealth landscape for weight management continues to evolve, with several developments on the horizon:

Regulatory Stability and Expansion

While the DEA’s temporary telehealth flexibility for controlled substances expires December 31, 2025, multiple signals suggest extensions or permanent rule-making will maintain expanded telehealth access. Congress is considering legislation like the TREATS Act that would permanently expand telehealth prescribing capabilities.

For weight loss medications specifically, which aren’t affected by controlled substance rules, the trend is clearly toward greater acceptance and fewer barriers as regulators recognize that telehealth can deliver quality care comparable to in-person visits.

State Law Harmonization

As more states join interstate licensure compacts and observe positive outcomes from telehealth weight management programs, we anticipate greater consistency in regulations across state lines. Several states with restrictive rules are considering legislation to ease telehealth requirements and expand nurse practitioner practice authority.

Insurance Coverage Improvements

More insurance plans are adding coverage for anti-obesity medications and telehealth consultations. Medicare has expanded telehealth benefits (though it still doesn’t cover weight loss medications), and many private insurers now include GLP-1s in their formularies with prior authorization.

New Medications and Combination Therapies

The pipeline of anti-obesity medications is robust, with several new GLP-1 agonists and dual-action medications in late-stage development. As these receive FDA approval, telehealth will likely be a primary distribution channel, making cutting-edge treatments accessible to more patients.

Frequently Asked Questions

Do I need to have an in-person visit before getting weight loss medication through telehealth?

It depends on your state. Many states (California, New York, Illinois, Pennsylvania, Washington) allow entirely telehealth-based prescribing without requiring in-person visits. However, several states (Arkansas, Georgia, Delaware, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Virginia) require or strongly recommend an initial in-person physical examination. Check the state-specific table earlier in this article for your location’s requirements.

Can nurse practitioners prescribe weight loss medications via telehealth?

Yes, nurse practitioners can prescribe GLP-1 weight loss medications in all states, though their level of independence varies. About 26 states allow NPs to practice and prescribe independently, while others require collaboration agreements with physicians. Regardless of the oversight model, NPs are qualified to manage weight loss treatment through telehealth platforms.

How much do weight loss medications cost through telehealth?

Costs vary significantly based on insurance coverage. Without insurance, brand-name medications like Wegovy typically cost $900-$1,300 per month. With insurance, copays may range from $25-$300 depending on your plan’s coverage and whether you’ve met your deductible. Telehealth consultation fees are separate and typically range from $50-$200 for initial visits, with lower costs for follow-ups. At Klarity Health, we work with both insurance and cash-pay patients to find the most affordable option.

Are telehealth-prescribed weight loss medications as safe as those prescribed in-person?

When prescribed through legitimate telehealth services that conduct thorough evaluations and provide ongoing monitoring, yes. The medications themselves are identical whether prescribed in-person or via telehealth. The key is ensuring your provider conducts an appropriate medical assessment, screens for contraindications, and maintains regular follow-up—all of which reputable telehealth platforms like Klarity Health provide.

What happens if I experience side effects from my weight loss medication?

Contact your telehealth provider immediately if you experience concerning side effects. Most GLP-1 side effects (nausea, constipation, mild GI upset) are manageable with dose adjustments or supportive care. Your provider may slow your dose escalation or recommend dietary modifications. For severe symptoms like persistent vomiting, severe abdominal pain, or signs of pancreatitis, seek immediate medical attention and notify your telehealth provider.

Can I switch from in-person care to telehealth for weight loss medication management?

Absolutely. Many patients start with in-person providers and transition to telehealth for convenience. You’ll need to establish care with a telehealth provider licensed in your state, and they’ll typically request records from your previous provider to ensure continuity of care. This transition is straightforward and can save you time while maintaining quality care.

Take the Next Step Toward Your Weight Loss Goals

If you’re ready to explore whether weight loss medication through telehealth is right for you, Klarity Health is here to help. Our experienced providers offer comprehensive evaluations, evidence-based treatment plans, and ongoing support—all from the comfort of your home.

Getting started is simple:

1. Complete a brief health assessment on our secure platform
2. Schedule a video consultation with a licensed provider in your state
3. Receive personalized treatment recommendations based on your medical history and goals
4. Get your prescription sent to your preferred pharmacy if medically appropriate
5. Access ongoing support with regular follow-ups and medication management

With transparent pricing, acceptance of most insurance plans, and flexible scheduling including evenings and weekends, Klarity Health makes quality weight loss care accessible when you need it.

Schedule your consultation today and take the first step toward sustainable weight loss with the support of experienced healthcare providers who put your safety and success first.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight loss medications are prescription drugs that require evaluation by a licensed healthcare provider. Individual results vary, and not all patients will qualify for medication therapy. Always consult with a qualified healthcare professional about your specific medical situation.

References and Sources

1. DEA Announcement (Nov 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025,’ U.S. Drug Enforcement Administration, November 15, 2024. Available at: www.dea.gov

2. Axios News – ‘COVID-era telehealth prescribing extended,’ Axios, November 18, 2024. Available at: www.axios.com

3. McDermott Law – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025,’ McDermott Will & Emery, November 18, 2024. Available at: www.mwe.com

4. Goodwin Law Alert – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs,’ Goodwin Procter LLP, March 27, 2024. Available at: www.goodwinlaw.com

5. Reuters News – ‘Hims & Hers cuts workforce amid ban on weight-loss drug copies,’ Reuters, May 30, 2025. Available at: www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid